JPMorgan lowered the firm’s price target on Alkami (ALKT) to $38 from $40 and keeps an Overweight rating on the shares post the Q3 report.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALKT:
- Alkami Technology: Buy Rating Affirmed Amid Strong Fundamentals and Attractive Valuation
- Alkami price target lowered to $40 from $46 at Citizens JMP
- Alkami price target lowered to $25 from $30 at Barclays
- Alkami Technology Reports Strong Q3 2025 Results
- Alkami Technology Appoints New CFO Amid Strong Q3 Results